Načítá se...
Selective Degradation of CDK6 by a Palbociclib Based PROTAC
Development of selective kinase inhibitors that target the ATP binding site continues to be a challenge largely due to similar binding pockets. Palbociclib is a cyclin-dependent kinase inhibitor that targets the ATP binding site of CDK4 and CDK6 with similar potency. The enzymatic function associate...
Uloženo v:
| Vydáno v: | Bioorg Med Chem Lett |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487213/ https://ncbi.nlm.nih.gov/pubmed/30935795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.03.035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|